SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-018406
Filing Date
2014-03-27
Accepted
2014-03-27 17:25:36
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v371069_10k.htm 10-K 1650338
2 EXHIBIT 21.1 v371069_ex21-1.htm EX-21.1 13313
3 EXHIBIT 23.1 v371069_ex23-1.htm EX-23.1 6855
4 EXHIBIT 31.1 v371069_ex31-1.htm EX-31.1 20805
5 EXHIBIT 31.2 v371069_ex31-2.htm EX-31.2 19706
6 EXHIBIT 32.1 v371069_ex32-1.htm EX-32.1 9153
7 EXHIBIT 32.2 v371069_ex32-2.htm EX-32.2 9136
  Complete submission text file 0001144204-14-018406.txt   8519441

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prph-20131231.xml EX-101.INS 1259517
9 XBRL TAXONOMY EXTENSION SCHEMA prph-20131231.xsd EX-101.SCH 56176
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20131231_cal.xml EX-101.CAL 46512
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20131231_def.xml EX-101.DEF 279863
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20131231_lab.xml EX-101.LAB 399795
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20131231_pre.xml EX-101.PRE 335804
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 14722622
SIC: 2834 Pharmaceutical Preparations